Dihydroergotamine Mesylate
Cluster Headache, Migraine Disorders
Treatment
4 Active Studies for Dihydroergotamine Mesylate
Treatment for
Cluster Headache
What is Dihydroergotamine Mesylate
Dihydroergotamine
The Generic name of this drug
Treatment Summary
Dihydroergotamine is a drug used to treat migraines. It is not as commonly used as other medications due to its less desirable side effects. However, recent advancements in intranasal delivery systems have made it more effective, allowing for a higher concentration of the medication to be delivered to the upper nasal cavity and resulting in a 3-fold increase in effectiveness.
Migranal
is the brand name
Dihydroergotamine Mesylate Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Migranal
Dihydroergotamine
1997
21
Effectiveness
How Dihydroergotamine Mesylate Affects Patients
DHE is used to treat migraine headaches and cluster headaches. It works by affecting the nerves and blood vessels in the brain, which can reduce the symptoms associated with the headaches. It does this by stimulating certain serotonin-related activities, which can lead to decreased activity in the trigeminal system, as well as cause constriction of the blood vessels. This can help reduce the pain of a migraine attack and also lead to the side effect of feeling tightness in the chest.
How Dihydroergotamine Mesylate works in the body
DHE works in multiple ways to relieve the effects of migraines. It constricts the blood vessels, which become widened during a migraine attack. It also decreases pain signals sent to the brain, and inhibits the release of chemicals that cause inflammation and pain. DHE has 10 times less potency than ergotamine, meaning it is less likely to cause side effects. However, it is hard to predict how DHE will affect someone due to its slow diffusion from receptors.
When to interrupt dosage
The measure of Dihydroergotamine Mesylate is predicated upon the diagnosed affliction. The amount of dosage is contingent upon the system of delivery (e.g. Intramuscular; Intravenous; Subcutaneous or Spray, metered) delineated in the accompanying table.
Condition
Dosage
Administration
Cluster Headache
, 1.0 mg/mL, 4.0 mg/mL, 2.5 mg, 0.5 mg/pump actuation
Intramuscular; Intravenous; Subcutaneous, , Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Spray, Spray - Nasal, Nasal, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Liquid - Nasal, Tablet - Oral, Oral, Tablet, Injection, Injection - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal
Migraine Disorders
, 1.0 mg/mL, 4.0 mg/mL, 2.5 mg, 0.5 mg/pump actuation
Intramuscular; Intravenous; Subcutaneous, , Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Spray, Spray - Nasal, Nasal, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Liquid - Nasal, Tablet - Oral, Oral, Tablet, Injection, Injection - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal
Warnings
Dihydroergotamine Mesylate Contraindications
Condition
Risk Level
Notes
Coronary Vasospasm
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Chest Pain
Do Not Combine
Pulse Frequency
Do Not Combine
Documented Silent Ischemia
Do Not Combine
Severe Hepatic Impairment
Do Not Combine
Renal Insufficiency
Do Not Combine
Migraine with Aura
Do Not Combine
Hypertensive disease
Do Not Combine
Liver Failure
Do Not Combine
Hemiplegic migraine
Do Not Combine
Vasospastic Angina
Do Not Combine
Women who are breast-feeding or pregnant
Do Not Combine
Vascular Surgery
Do Not Combine
Peripheral Arterial Disease
Do Not Combine
Pulse Frequency
Do Not Combine
Coronary Artery Disease
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Dihydroergotamine may interact with Pulse Frequency
There are 20 known major drug interactions with Dihydroergotamine Mesylate.
Common Dihydroergotamine Mesylate Drug Interactions
Drug Name
Risk Level
Description
4-Bromo-2,5-dimethoxyphenethylamine
Major
Dihydroergotamine may increase the hypertensive and vasoconstricting activities of 4-Bromo-2,5-dimethoxyphenethylamine.
4-Methoxyamphetamine
Major
Dihydroergotamine may increase the hypertensive and vasoconstricting activities of 4-Methoxyamphetamine.
5-methoxy-N,N-dimethyltryptamine
Major
Dihydroergotamine may increase the vasoconstricting activities of 5-methoxy-N,N-dimethyltryptamine.
Abediterol
Major
Dihydroergotamine may increase the hypertensive and vasoconstricting activities of Abediterol.
Abemaciclib
Major
The metabolism of Abemaciclib can be decreased when combined with Dihydroergotamine.
Dihydroergotamine Mesylate Toxicity & Overdose Risk
Overdosing on ergot can cause numbness, tingling, pain, and a bluish discoloration of the extremities along with weak or no pulses. Other symptoms may include shallow or absent breathing, changes in blood pressure, confusion, hallucinations, seizures, and vomiting. Those affected should be kept warm and given vasodilators as treatment. Contact local poison control for more information on how to treat ergot overdose.
Dihydroergotamine Mesylate Novel Uses: Which Conditions Have a Clinical Trial Featuring Dihydroergotamine Mesylate?
A total of 7 active studies are exploring the efficacy of Dihydroergotamine Mesylate in treating Cluster Headache.
Condition
Clinical Trials
Trial Phases
Migraine Disorders
1 Actively Recruiting
Not Applicable
Cluster Headache
2 Actively Recruiting
Phase 1, Phase 2
Dihydroergotamine Mesylate Reviews: What are patients saying about Dihydroergotamine Mesylate?
5
Patient Review
6/20/2013
Dihydroergotamine Mesylate for Migraine Headache
5
Patient Review
3/1/2012
Dihydroergotamine Mesylate for Migraine Headache
5
Patient Review
1/21/2018
Dihydroergotamine Mesylate for Migraine Headache
5
Patient Review
8/7/2013
Dihydroergotamine Mesylate for Migraine Headache
5
Patient Review
7/22/2010
Dihydroergotamine Mesylate for Migraine Headache
5
Patient Review
12/6/2010
Dihydroergotamine Mesylate for Migraine Headache
5
Patient Review
8/8/2011
Dihydroergotamine Mesylate for Migraine Headache
5
Patient Review
8/17/2011
Dihydroergotamine Mesylate for Migraine Headache
5
Patient Review
1/19/2016
Dihydroergotamine Mesylate for Migraine Headache
4.7
Patient Review
4/8/2022
Dihydroergotamine Mesylate for Migraine Headache
4.7
Patient Review
4/29/2013
Dihydroergotamine Mesylate for Migraine Headache
4.7
Patient Review
4/14/2011
Dihydroergotamine Mesylate for Migraine Headache
4.7
Patient Review
7/29/2011
Dihydroergotamine Mesylate for Migraine Headache
4
Patient Review
4/25/2021
Dihydroergotamine Mesylate for Migraine Headache
3
Patient Review
12/15/2011
Dihydroergotamine Mesylate for Migraine Headache
2
Patient Review
10/23/2012
Dihydroergotamine Mesylate for Migraine Headache
2
Patient Review
3/29/2011
Dihydroergotamine Mesylate for Migraine Headache
1.7
Patient Review
7/13/2015
Dihydroergotamine Mesylate for Migraine Headache
1.7
Patient Review
3/26/2012
Dihydroergotamine Mesylate for Migraine Headache
Patient Q&A Section about dihydroergotamine mesylate
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the common name for dihydroergotamine?
"DHE is used to relieve migraines. The active ingredient, dihydroergotamine, is an alkaloid that is derived from ergot. DHE is available in both injectable and nasal spray forms."
Answered by AI
Is dihydroergotamine mesylate a narcotic?
"It is used as a non-narcotic analgesic, a vasoconstrictor agent, and a serotonergic agonist. It contains a 9,10alpha-dihydro derivative of ERGOTAMINE."
Answered by AI
How much does dihydroergotamine cost?
"The average cost of Dihydroergotamine Mesylate without insurance is $3,796.69, but the price may vary depending on the dosage prescribed. However, with a SingleCare coupon, the cost of Dihydroergotamine Mesylate is only $905.19 per 1, 1ML of 4MG/ML Solution."
Answered by AI